In our World Campus October session: From Bench to Bedside – How Regulatory Science and Patient Perspective Drive Smarter Drug Development
Presentation by Khaled Bouri, Independent Consultant and Former FDA Expert
In this World Campus October session, Khaled Bouri explores the critical role of regulatory science in advancing drug development from the laboratory to patient care. Regulatory science is essentially the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of products regulated by agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
The session covers:
-
Regulatory science in drug development: How it supports each stage, from early research to clinical trials and market approval.
-
Key regulatory checkpoints: Understanding the risk-benefit framework that underpins regulatory decision-making.
-
Patient perspectives: Innovative mechanisms to include patient input, ensuring that treatments align with real-world needs and priorities.
This presentation offers valuable insights for researchers, industry professionals, and anyone interested in how science and patient voices shape smarter, safer, and more effective therapies.
Watch the full session here:
